Becton, Dickinson and Company (BDX) stock analysis

In our weekly check, Becton, Dickinson and Company is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 9, red flags: 2.

About Becton, Dickinson and Company

Becton, Dickinson and Company is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NYSE as BDX.

What our checks show for BDX

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-08

Similar companies

MDLN · RMD · WST · ISRG · SOLV · BAX

Questions

What grade does Becton, Dickinson and Company (BDX) have?

In our weekly check, Becton, Dickinson and Company is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 9, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of BDX stock?

This week's biggest flags for Becton, Dickinson and Company: Margins falling, Dividend stretched, High debt. In total 11 of 25 checks show a warning or a red flag.

What does Becton, Dickinson and Company do?

Becton, Dickinson and Company is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NYSE as BDX.

When does Becton, Dickinson and Company report earnings next?

The next earnings report is expected on 2027-02-08. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis